latest news releases from the newsroom
CME Group to Move Listing to The NASDAQ Stock Market
NEW YORK, June 30, 2008 (PRIME NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that CME Group (Nasdaq:CME) (NYSE:CME) will list its common stock solely on The NASDAQ Global Select Market. CME Group will cease listing on the NYSE on July 11, 2008 and commence trading on The NASDAQ Global Select Market on July 14, 2008 under the symbol (Nasdaq:CME). CME Group has been listed on the NYSE since December 2002 and dually listed its stock on the NASDAQ in May 2005.
Talon Therapeutics, Inc.
Hana Biosciences Receives U.S. Orphan Drug Designation for Marqibo for the Treatment of Metastatic Uveal Melanoma
SOUTH SAN FRANCISCO, Calif., June 30, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Marqibo(r) (vincristine sulfate injection, OPTISOME(tm)) for the treatment of adult patients with metastatic uveal melanoma. Orphan drug designation offers significant benefits to Hana Biosciences, including financial incentives and market exclusivity for a period of seven years.
Xstream Mobile Solutions Inc.
Xstream Mobile Solutions Announces Emergence Into the Large University Marketplace
CHICAGO, June 30, 2008 (PRIME NEWSWIRE) -- Xstream Mobile Solutions (Pink Sheets:XMSC) is proud to announce the deployment of Xstream SAFE, their flagship Emergency Notification System, at Northern Illinois University (NIU). This affiliation represents the bold first step of Xstream Mobile Solution's emergence into the large university marketplace. Preliminary installation began in May and the system is intended to be tested in late summer with full functionality expected during the fall semester of 2008.